Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug

Investors cheer what may be a cheap way to play the current weight-loss drug mania.

Previous post Smucker’s profit tops estimates as Hostess acquisition sweetens its business
Next post Citigroup’s stock wins another upgrade as analysts cheer turnaround plan